Stock screener

BTMD

Conviction 20HealthcareScan · Mon, Aug 10, 2026
Bullish harami
BTMD$1.54+3.72%
ResistanceSupportVol 14
63 bars
Vol MA14 237.54K
May 11May 28Jun 16Jul 6Jul 23Aug 10
biote Corp.MEDICINAL CHEMICALS & BOTANICAL PRODUCTSwww.biote.com
Price1.54
Change+3.72%
Gap+3.04%
Rel volume2.40×
Avg volume240.95K
Avg $ vol490.37K
SMA 202.18
SMA 502.18
SMA 2002.22
Price vs 50-29.62%
Price vs 200-30.74%
MA stackbearish
50/200 cross
Supertrenddown · 2.15
RSI (14)31
MACD hist-0.09
MACD cross
Stoch %K / %D8 / 6
ADX (14)22
+DI / −DI11 / 39
RSI divergence
MACD divergence
ATR %+13.07%
ADR %8.76%
52w high3.49
52w low1.30
From 52w high-56.02%
Above 52w low+18.08%
New 52w highNo
SqueezeOff
Bollinger width52.62%
%B-0.06
Donchian pos7.39%
Donchian high2.60
Donchian low1.45
AVWAP (52w high)2.16
vs AVWAP high-28.95%
AVWAP (52w low)1.98
vs AVWAP low-22.28%
OBV trendFlat
Chaikin MF (20)-0.12
Today vs 20d2.40×
Avg vol (14d)237.54K
Avg vol (20d)240.95K
Avg $ vol (20d)490.37K
Market cap89.37M
RS 3m (vs SPY)-34.88%
RS 6m (vs SPY)-44.30%
RS line new highNo
Trend template0/8
Technical rank7.0
1 week-32.97%
1 month-34.12%
3 months-29.59%
6 months-31.17%
1 year-47.43%
YTD-37.85%
P/E3.30
P/B-1.36
P/S0.46
P/FCF2.96
EPS0.7400
Div yield1.93%
ROE-41.11%
ROA26.59%
Debt/Eq-1.85
Current1.43
EV/EBITDA5.09
Gross margin
Net margin14.07%
Rev growth-2.52%
EPS growth756.67%
Price target
Target upside
Analyst rating
Institutional
Ent. value199.7M
Revenue44.23M
Net income-6.56M
Gross profit
Free cash flow30.18M
IndustryMEDICINAL CHEMICALS & BOTANICAL PRODUCTS
ExchangeNasdaq
Shares out30.33M
Employees223
ListedFri, May 27, 2022
Free float14.96M
Float %46.4%
Short interest578.68K
Days to cover2.8d
Short volume23.9%
Squeeze score37 / 100
Next earnings
EPS forecast
Last EPS vs est$0.00 vs $0.03
Last surprise-100.0% miss
Setup gradeD
Conviction20 / 100
Pattern quality
Tech rank7.0 / 100
Group rank86 / 100 · Leading
Status lane
Setup direction
Pattern family
Resistance
Support
Days since event
Candle confirmBullish harami
News sentiment

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in BTMD

All disclosures →
No recent disclosed trades by Congress in BTMD. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in BTMD · 9 buys · 1 sell

InsiderSideShares
Christensen Bret
Director · Stock Option (Right to Buy) · 2026-06-08
Grant130K
Beer Marc D
Executive Chairman · Employee Stock Option (Right to Buy) · 2026-06-08
Grant114.16K
HEYER ANDREW R
Director · Deferred Settlement RSU · 2026-05-12
Grant35.26K
HEYER ANDREW R
Director · Stock Option (Right to Buy) · 2026-05-12
Grant130K
MORRIS DEBRA L
Director · Class A Common Stock · 2026-05-12
Exercise21.41K
Cone Stephen Mark
Director · Deferred Settlement RSU · 2026-05-12
Grant31.48K
Jacoby Dana Lynn
Director · Deferred Settlement RSU · 2026-05-12
Grant37.78K
Cone Stephen Mark
Director · Stock Option (Right to Buy) · 2026-05-12
Grant130K
Barrera Richard R
Director · Stock Option (Right to Buy) · 2026-05-12
Grant121.45K
MORRIS DEBRA L
Director · Deferred Settlement RSU · 2026-05-12
Exercise21.41K

SEC filings

EDGAR filings in BTMD · 5 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.